Veradigm Analyst Ratings
Veradigm Analyst Ratings
Veradigm 分析师评级
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/10/2023 | -6.64% | Stephens & Co. | → $13 | Reiterates | Equal-Weight → Equal-Weight |
| 07/06/2023 | — | Argus Research | Downgrades | Buy → Hold | |
| 04/12/2023 | -6.64% | Stephens & Co. | → $13 | Initiates Coverage On | → Equal-Weight |
| 02/01/2023 | 32.85% | Piper Sandler | $17 → $18.5 | Downgrades | Overweight → Neutral |
| 12/07/2022 | 86.71% | Argus Research | → $26 | Upgrades | Hold → Buy |
| 11/18/2022 | 43.63% | JP Morgan | $19 → $20 | Maintains | Underweight |
| 11/09/2022 | 65.17% | Goldman Sachs | $22 → $23 | Upgrades | Neutral → Buy |
| 09/16/2022 | — | Keybanc | Initiates Coverage On | → Sector Weight | |
| 07/12/2022 | 50.81% | Goldman Sachs | → $21 | Initiates Coverage On | → Neutral |
| 06/10/2022 | 22.08% | Piper Sandler | $19 → $17 | Maintains | Neutral |
| 05/06/2022 | 36.45% | Piper Sandler | $22 → $19 | Maintains | Neutral |
| 03/18/2022 | 57.99% | Piper Sandler | $19 → $22 | Maintains | Neutral |
| 03/04/2022 | 86.71% | Deutsche Bank | $20 → $26 | Upgrades | Hold → Buy |
| 03/03/2022 | 72.35% | SVB Leerink | $22 → $24 | Maintains | Outperform |
| 01/25/2022 | 57.99% | SVB Leerink | $19 → $22 | Upgrades | Market Perform → Outperform |
| 11/23/2021 | 43.63% | Deutsche Bank | $18 → $20 | Maintains | Hold |
| 08/06/2021 | 36.45% | RBC Capital | $17 → $19 | Maintains | Outperform |
| 08/06/2021 | 36.45% | SVB Leerink | $17 → $19 | Maintains | Market Perform |
| 05/26/2021 | 22.08% | SVB Leerink | $16 → $17 | Maintains | Market Perform |
| 04/30/2021 | 14.9% | SVB Leerink | $15 → $16 | Maintains | Market Perform |
| 04/30/2021 | 29.26% | Canaccord Genuity | $17 → $18 | Maintains | Buy |
| 03/02/2021 | — | Argus Research | Downgrades | Buy → Hold | |
| 02/26/2021 | 7.72% | SVB Leerink | $16 → $15 | Maintains | Market Perform |
| 11/25/2020 | 18.49% | B of A Securities | $14 → $16.5 | Maintains | Buy |
| 10/19/2020 | -6.64% | Baird | → $13 | Downgrades | Outperform → Neutral |
| 10/14/2020 | -6.64% | Cantor Fitzgerald | $9 → $13 | Maintains | Neutral |
| 10/14/2020 | -6.64% | SVB Leerink | $10 → $13 | Maintains | Market Perform |
| 08/24/2020 | -35.37% | JP Morgan | $8 → $9 | Maintains | Neutral |
| 08/11/2020 | -42.55% | Morgan Stanley | $6 → $8 | Maintains | Underweight |
| 08/03/2020 | -28.19% | RBC Capital | $8 → $10 | Maintains | Outperform |
| 07/31/2020 | -35.37% | Cantor Fitzgerald | $6 → $9 | Maintains | Neutral |
| 07/31/2020 | -28.19% | SVB Leerink | $6 → $10 | Maintains | Market Perform |
| 07/21/2020 | -60.5% | Goldman Sachs | $6.5 → $5.5 | Downgrades | Neutral → Sell |
| 05/13/2020 | -56.91% | Morgan Stanley | $5 → $6 | Maintains | Underweight |
| 05/13/2020 | -49.73% | SunTrust Robinson Humphrey | $6 → $7 | Maintains | Hold |
| 05/08/2020 | -56.91% | SVB Leerink | $8 → $6 | Maintains | Market Perform |
| 05/08/2020 | -56.91% | Cantor Fitzgerald | $8 → $6 | Reiterates | → Neutral |
| 04/22/2020 | -49.73% | Jefferies | $10.5 → $7 | Downgrades | Buy → Hold |
| 04/21/2020 | -42.55% | RBC Capital | → $8 | Initiates Coverage On | → Outperform |
| 03/05/2020 | -35.37% | SunTrust Robinson Humphrey | $11 → $9 | Maintains | Hold |
| 03/04/2020 | -21.01% | Deutsche Bank | $12 → $11 | Maintains | Hold |
| 03/03/2020 | -56.91% | CFRA | $9 → $6 | Maintains | Strong Sell |
| 03/03/2020 | -28.19% | Baird | $13 → $10 | Maintains | Outperform |
| 03/03/2020 | -42.55% | Cantor Fitzgerald | $11 → $8 | Reiterates | → Neutral |
| 11/26/2019 | -17.41% | UBS | → $11.5 | Initiates Coverage On | → Neutral |
| 09/26/2019 | -21.01% | Deutsche Bank | → $11 | Initiates Coverage On | → Hold |
| 02/25/2019 | -13.82% | Citigroup | $14 → $12 | Downgrades | Buy → Neutral |
| 02/22/2019 | — | Keybanc | Downgrades | Overweight → Sector Weight | |
| 02/22/2019 | -13.82% | Citigroup | $14 → $12 | Downgrades | Buy → Neutral |
| 01/18/2019 | — | Keybanc | Upgrades | Sector Weight → Overweight | |
| 11/14/2018 | — | Argus Research | Downgrades | Buy → Hold | |
| 11/02/2018 | 7.72% | B of A Securities | $16.5 → $15 | Maintains | Buy |
| 11/02/2018 | 0.54% | Baird | $16 → $14 | Maintains | Outperform |
| 11/02/2018 | 22.08% | Citigroup | $19 → $17 | Maintains | Buy |
| 11/02/2018 | -13.82% | JP Morgan | $16 → $12 | Downgrades | Overweight → Neutral |
| 11/02/2018 | -13.82% | Cantor Fitzgerald | → $12 | Downgrades | Overweight → Neutral |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 2023年10月10日 | -6.64% | 斯蒂芬斯公司 | →$13 | 重申 | 等重→等重 |
| 07/06/2023 | - | Argus研究 | 评级下调 | 购买→Hold | |
| 04/12/2023 | -6.64% | 斯蒂芬斯公司 | →$13 | 开始承保 | →等重 |
| 02/01/2023 | 32.85% | 派珀·桑德勒 | $17→$18.5 | 评级下调 | 超重→中性 |
| 12/07/2022 | 86.71% | Argus研究 | →$26 | 升级 | 持有→购买 |
| 2022年11月18日 | 43.63% | 摩根大通 | $19→$20 | 维护 | 体重不足 |
| 11/09/2022 | 65.17% | 高盛 | $22→$23 | 升级 | 中性→购买 |
| 09/16/2022 | - | KeyBanc | 开始承保 | →行业权重 | |
| 07/12/2022 | 50.81% | 高盛 | →$21 | 开始承保 | →中性 |
| 2022/10/06 | 22.08% | 派珀·桑德勒 | $19→$17 | 维护 | 中性 |
| 05/06/2022 | 36.45% | 派珀·桑德勒 | $22→$19 | 维护 | 中性 |
| 03/18/2022 | 57.99% | 派珀·桑德勒 | $19→$22 | 维护 | 中性 |
| 03/04/2022 | 86.71% | 德意志银行 | $20→$26 | 升级 | 持有→购买 |
| 03/03/2022 | 72.35% | SVB Leerink | $22→$24 | 维护 | 跑赢大盘 |
| 01/25/2022 | 57.99% | SVB Leerink | $19→$22 | 升级 | 市场表现优于→ |
| 2021年11月23日 | 43.63% | 德意志银行 | $18→$20 | 维护 | 保持 |
| 08/06/2021 | 36.45% | 加拿大皇家银行资本 | $17→$19 | 维护 | 跑赢大盘 |
| 08/06/2021 | 36.45% | SVB Leerink | $17→$19 | 维护 | 市场表现 |
| 2021/05/26 | 22.08% | SVB Leerink | $16→$17 | 维护 | 市场表现 |
| 04/30/2021 | 14.9% | SVB Leerink | $15→$16 | 维护 | 市场表现 |
| 04/30/2021 | 29.26% | 卡纳科特·格纳奇 | $17→$18 | 维护 | 买 |
| 03/02/2021 | - | Argus研究 | 评级下调 | 购买→Hold | |
| 02/26/2021 | 7.72% | SVB Leerink | $16→$15 | 维护 | 市场表现 |
| 11/25/2020 | 18.49% | B of A证券 | $14→$16.5 | 维护 | 买 |
| 10/19/2020 | -6.64% | 贝尔德 | →$13 | 评级下调 | 跑赢→中性 |
| 10/14/2020 | -6.64% | 康托·菲茨杰拉德 | $9→$13 | 维护 | 中性 |
| 10/14/2020 | -6.64% | SVB Leerink | $10→$13 | 维护 | 市场表现 |
| 08/24/2020 | -35.37% | 摩根大通 | $8→$9 | 维护 | 中性 |
| 2020年08月11日 | -42.55% | 摩根士丹利 | $6→$8 | 维护 | 体重不足 |
| 08/03/2020 | -28.19% | 加拿大皇家银行资本 | $8→$10 | 维护 | 跑赢大盘 |
| 07/31/2020 | -35.37% | 康托·菲茨杰拉德 | $6→$9 | 维护 | 中性 |
| 07/31/2020 | -28.19% | SVB Leerink | $6→$10 | 维护 | 市场表现 |
| 07/21/2020 | -60.5% | 高盛 | $6.5→$5.5 | 评级下调 | 中性→销售 |
| 2020/05/13 | -56.91% | 摩根士丹利 | $5→$6 | 维护 | 体重不足 |
| 2020/05/13 | -49.73% | SunTrust Robinson Humphrey | $6→$7 | 维护 | 保持 |
| 05/08/2020 | -56.91% | SVB Leerink | $8→$6 | 维护 | 市场表现 |
| 05/08/2020 | -56.91% | 康托·菲茨杰拉德 | $8→$6 | 重申 | →中性 |
| 04/22/2020 | -49.73% | 杰富瑞 | $10.5→$7 | 评级下调 | 购买→Hold |
| 04/21/2020 | -42.55% | 加拿大皇家银行资本 | →$8 | 开始承保 | →跑赢大盘 |
| 03/05/2020 | -35.37% | SunTrust Robinson Humphrey | $11→$9 | 维护 | 保持 |
| 03/04/2020 | -21.01% | 德意志银行 | $12→$11 | 维护 | 保持 |
| 03/03/2020 | -56.91% | CFRA | $9→$6 | 维护 | 强劲的销售 |
| 03/03/2020 | -28.19% | 贝尔德 | $13→$10 | 维护 | 跑赢大盘 |
| 03/03/2020 | -42.55% | 康托·菲茨杰拉德 | $11→$8 | 重申 | →中性 |
| 2019年11月26日 | -17.41% | 瑞银集团 | →$11.5 | 开始承保 | →中性 |
| 2019年09月26日 | -21.01% | 德意志银行 | →$11 | 开始承保 | →保留 |
| 2019年02月25日 | -13.82% | 花旗集团 | $14→$12 | 评级下调 | 购买→中性 |
| 2019年02月22日 | - | KeyBanc | 评级下调 | 增持→板块权重 | |
| 2019年02月22日 | -13.82% | 花旗集团 | $14→$12 | 评级下调 | 购买→中性 |
| 2019年01月18日 | - | KeyBanc | 升级 | 行业权重→超配 | |
| 2018年11月14日 | - | Argus研究 | 评级下调 | 购买→Hold | |
| 11/02/2018 | 7.72% | B of A证券 | $16.5→$15 | 维护 | 买 |
| 11/02/2018 | 0.54% | 贝尔德 | $16→$14 | 维护 | 跑赢大盘 |
| 11/02/2018 | 22.08% | 花旗集团 | $19→$17 | 维护 | 买 |
| 11/02/2018 | -13.82% | 摩根大通 | $16→$12 | 评级下调 | 超重→中性 |
| 11/02/2018 | -13.82% | 康托·菲茨杰拉德 | →$12 | 评级下调 | 超重→中性 |
What is the target price for Veradigm (MDRX)?
Veradigm的目标价是多少？
The latest price target for Veradigm (NASDAQ: MDRX) was reported by Stephens & Co. on October 10, 2023. The analyst firm set a price target for $13.00 expecting MDRX to fall to within 12 months (a possible -6.64% downside). 7 analyst firms have reported ratings in the last year.
斯蒂芬斯公司于2023年10月10日报道了Veradigm(纳斯达克代码：MDRX)的最新目标价。这家分析公司将MDRX的目标价设定为13.00美元，预计MDRX将在12个月内下跌(可能下跌6.64%)。去年有7家分析公司公布了评级。
What is the most recent analyst rating for Veradigm (MDRX)?
最新的分析师对Veradigm的评级是多少？
The latest analyst rating for Veradigm (NASDAQ: MDRX) was provided by Stephens & Co., and Veradigm reiterated their equal-weight rating.
斯蒂芬斯公司提供了对Veradigm(纳斯达克代码：MDRX)的最新分析师评级，Veradigm重申了它们的同等权重评级。
When is the next analyst rating going to be posted or updated for Veradigm (MDRX)?
Veradigm(MDRX)的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Veradigm, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Veradigm was filed on October 10, 2023 so you should expect the next rating to be made available sometime around October 10, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括查阅公共财务报表，与Veradigm的高管和客户交谈，以及收听收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。Veradigm的上一次评级是在2023年10月10日提交的，所以你应该预计下一次评级将在2024年10月10日左右的某个时候公布。
Is the Analyst Rating Veradigm (MDRX) correct?
分析师评级Veradigm(MDRX)正确吗？
While ratings are subjective and will change, the latest Veradigm (MDRX) rating was a reiterated with a price target of $0.00 to $13.00. The current price Veradigm (MDRX) is trading at is $13.93, which is out of the analyst's predicted range.
虽然评级是主观的，并将发生变化，但最新的Veradigm(MDRX)评级被重申，目标价在0.00美元至13.00美元之间。目前Veradigm的交易价格为13.93美元，超出了分析师的预测区间。